Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

Exit

Closed Date1/2014

General Information

Websitesatoripharma.com
Twitter@SatoriPharma
CategoryMedical
Phone(617) 547-0022
Employees
Founded2005
DescriptionAlzheimer's Therapies

Offices

Cambridge, USA
281 Albany Street
Cambridge, MA, 02139
USA

People

CEO, Board of Directors
Co-Founder, Senior VP Research
VP Chemistry

Funding

TOTAL $47.3M
FUNDING TOTAL $47.3M
Venture Round, 1/2005
PureTech Ventures
$3M
Series A, 1/2009
InterWest Partners
Prospect Venture Partners
New Enterprise Associates
PureTech Ventures
$22M
Venture Round, 4/2010
$315k
Partial Close, 1/2011
$7M
Venture Round, 2/2012
InterWest Partners
New Enterprise Associates
Prospect Venture Partners
$15M

Tags

Satori Pharmaceuticals Closed down January, 2014

Satori Pharmaceuticals

Satori Pharmaceuticals is a neuroscience company focused on the discovery and development of disease-modifying therapies for Alzheimer’s disease, Parkinson’s disease and other neurodegenerative disorders.

Recent Milestones

Videos

Screenshots

Satori Pharmaceuticals screenshot
Above: Home Page
Uploaded: 2/24/12

Sources

  1. Satori (satoripharma.com) [edit]
  2. Satori (satoripharma.com) [edit]
  3. SEC (sec.gov) [edit]
  4. SEC (sec.gov) [edit]
  5. Satori Pharmaceuticals Raises $15M (finsmes.com) [edit]
  6. Satori socks away $7M in new $20M funding (masshightech.com) [edit]
Edit This Page
Last Edited 1/28/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy